智擎

-0.80 (-1.46%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

54.00487成交張數14.59本益比1.58股價淨值比3.70%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	54	49	9.4%	11.20	33.70	11.3%	9.7%	1.0	–
2026Q1	53	51	4.1%	29.16	34.76	8.0%	7.5%	2.6	–
2025Q4	51	49	4.3%	27.17	33.81	7.5%	7.0%	1.3	1.3
2025Q3	49	48	2.3%	43.53	32.91	38.2%	37.4%	0.5	0.5
2025Q2	57	47	18.5%	5.38	31.98	38.1%	32.8%	-2.6	-2.6
2025Q1	60	55	7.6%	13.34	37.77	37.5%	35.4%	18.1	18.1
2024Q4	58	54	7.7%	13.15	37.07	37.8%	35.7%	1.2	1.2
2024Q3	41	40	1.9%	53.67	27.33	9.5%	9.3%	0.8	0.8
2024Q2	42	39	7.8%	13.07	26.70	9.4%	8.6%	1.7	1.7
2024Q1	41	39	2.9%	36.85	27.08	7.0%	6.8%	0.8	0.8
2023Q4	40	39	2.3%	46.78	26.52	7.1%	6.9%	0.8	0.7
2023Q3	39	38	1.9%	61.92	26.26	7.6%	7.4%	-0.1	-0.1
2023Q2	42	37	10.4%	9.83	25.70	8.0%	7.1%	1.0	–
2023Q1	41	40	2.4%	48.86	27.15	7.6%	7.4%	0.9	–
2022Q4	40	39	2.4%	49.86	26.58	8.2%	8.0%	0.4	0.4
2022Q3	39	38	2.5%	39.87	26.20	9.8%	9.6%	0.6	0.6
2022Q2	42	37	11.4%	8.77	25.61	9.2%	8.5%	0.4	–
2022Q1	41	40	1.9%	51.12	27.72	11.0%	10.7%	0.6	–
2021Q4	40	39	2.2%	45.71	26.87	10.7%	10.3%	1.0	–
2021Q3	39	38	2.0%	50.85	26.12	22.9%	22.2%	0.2	–
2021Q2	43	42	3.3%	31.84	28.41	20.5%	19.6%	1.2	–
2021Q1	43	41	4.3%	24.53	27.88	16.6%	15.9%	6.9	–
2020Q4	42	40	4.7%	22.61	27.36	16.1%	15.4%	-0.0	-0.0
2020Q3	36	35	3.8%	28.49	23.78	1.3%	1.2%	0.2	–
2020Q2	37	35	6.2%	17.19	23.64	1.4%	1.3%	0.0	–
2020Q1	37	35	4.0%	28.18	24.09	1.8%	1.7%	0.4	–
2019Q4	36	35	4.4%	25.85	23.75	1.2%	1.1%	-0.6	-0.6
2019Q3	37	35	4.5%	22.83	23.99	3.1%	3.0%	0.3	0.3
2019Q2	38	35	7.9%	12.91	23.82	4.6%	4.2%	0.2	–
2019Q1	38	36	3.9%	27.21	24.61	5.5%	5.3%	0.2	–
2018Q4	38	37	4.0%	25.02	25.08	3.4%	3.3%	0.5	0.5
2018Q3	38	37	1.3%	79.58	25.31	18.3%	18.0%	0.7	0.7
2018Q2	40	36	8.8%	11.27	24.78	16.3%	14.7%	-0.4	-0.4
2018Q1	41	39	4.6%	21.43	26.28	12.3%	11.8%	6.7	6.7
2017Q4	41	39	4.9%	20.37	26.58	10.0%	9.6%	-0.2	-0.2
2017Q3	34	34	1.4%	72.44	22.80	13.8%	13.7%	-0.4	-0.4
2017Q2	37	34	10.2%	9.70	27.36	11.2%	10.2%	-1.1	-1.1
2017Q1	38	37	3.7%	26.81	30.09	17.8%	17.3%	-1.6	-1.6
2016Q4	40	38	4.0%	26.23	31.02	–	–	7.8	7.8
2016Q3	32	32	0.7%	172.54	25.93	–	–	-1.0	-1.0